How much funding has PACT Pharma raised?

PACT Pharma has raised $170.0M in total funding, most recently a Series C round.

Who are PACT Pharma's investors?

PACT Pharma's investors include GV, Vida Ventures, AbbVie Ventures, Canaan Partners, Casdin Capital.

When was PACT Pharma founded?

PACT Pharma was founded in 2017.

Where is PACT Pharma headquartered?

PACT Pharma is headquartered in South San Francisco, California, United States.

What industry is PACT Pharma in?

PACT Pharma operates in Biotech, Healthcare.

How many employees does PACT Pharma have?

PACT Pharma has 51-200 employees.

PACT Pharma

Personalized cancer therapy through precision genome engineering

South San Francisco, United States · Founded 2017 · $170.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2017
Business Model: B2B

Website: pactpharma.com
Total Funding: $170.0M
Last Round: $75.0M Series CMar 2024
Rounds: 2

About

PACT Pharma is a clinical-stage biopharma pioneering personalized neoantigen TCR therapies for solid tumors. PACT^NV platform uses non-viral CRISPR gene editing. Lead NeoTCR-P1.

Summary

PACT Pharma is a Biotech company based in South San Francisco, United States, founded in 2017. It has raised $170.0M in total across 2 rounds, most recently a $75.0M Series C round in Mar 2024. Investors include GV, Vida Ventures and AbbVie Ventures.

LinkedIn X (Twitter)